Skip to content
Nonprofiteer
← TEXANS FOR VACCINE CHOICE

Form 990 for tax year 2023

Filed by TEXANS FOR VACCINE CHOICE.

Totals

Total revenue
$339,693
Total expenses
$322,834
Contributions and grants received
$333,225
Grants paid
$0
Program service revenue
$784
Investment income
$0
Other revenue
$5,684
Total assets, end of year
$101,394
Total liabilities, end of year
$612
Net assets or fund balances, end of year
$100,782
Program services expenses (Part IX)
$302,166
Management and general expenses
$20,668
Fundraising expenses
$0
Program service expenses (Part III)
$302,166

Program services were 93.6% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Listed in Part VII

  • Christine Welborn

    Director

    Total calculated
    $30,833
    From this org
    $9,000
    From related orgs
    $21,833
    Other
    $0
    Hours/week
    15 + 20 related
  • Rebecca Hardy

    President

    Total calculated
    $10,800
    From this org
    $10,800
    From related orgs
    $0
    Other
    $0
    Hours/week
    40
  • Angie Lemmons

    Director

    Total calculated
    $0
    Hours/week
    10

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.

Grants on this return

No itemized grants to organizations on this return.

Provenance

Return type
form_990
Tax year
2023
Filed
15 November 2024
IRS schema version
2023v5.1
Source object
202433209349325103

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.